CEL-SCI Corp logo

CEL-SCI Corp

1
AMEX:CVM (USA)  
$ 0.66 +0.0476 (+7.79%) 12:08 AM EST
At Loss
P/B:
4.22
Market Cap:
$ 42.02M
Enterprise V:
$ 53.77M
Volume:
210.31K
Avg Vol (2M):
355.78K
Trade In:
Volume:
210.31K
At Loss
Avg Vol (2M):
355.78K

Business Description

Description
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
Name Current Vs Industry Vs History
Cash-To-Debt 0.03
Equity-to-Asset 0.35
Debt-to-Equity 1.43
Debt-to-EBITDA -0.51
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 64.58
9-Day RSI 49.32
14-Day RSI 41.81
6-1 Month Momentum % -28.42
12-1 Month Momentum % -59.6

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.64
Quick Ratio 0.18
Cash Ratio 0.07

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -7
Shareholder Yield % -25.98
Name Current Vs Industry Vs History
ROE % -224.2
ROA % -97.63
ROIC % -112.61
ROC (Joel Greenblatt) % -138.15
ROCE % -116.01

GF Value Rank

Name Current Vs Industry Vs History
PB Ratio 4.22
Price-to-Tangible-Book 4.39
EV-to-EBIT -1.94
EV-to-EBITDA -2.27
EV-to-FCF -2.81
Earnings Yield (Greenblatt) % -51.55
FCF Yield % -45.54

Financials (Next Earnings Date:2025-02-14 Est.)

CVM's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with AMEX:CVM

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

CEL-SCI Corp Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.58
Beta 0.51
Volatility % 48.99
14-Day RSI 41.81
14-Day ATR ($) 0.046683
20-Day SMA ($) 0.657975
12-1 Month Momentum % -59.6
52-Week Range ($) 0.5402 - 3.23
Shares Outstanding (Mil) 63.81

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

CEL-SCI Corp Filings

Filing Date Document Date Form
No Filing Data

CEL-SCI Corp Stock Events

Financials Calendars
Event Date Price($)
No Event Data

CEL-SCI Corp Frequently Asked Questions

What is CEL-SCI Corp(CVM)'s stock price today?
The current price of CVM is $0.66. The 52 week high of CVM is $3.23 and 52 week low is $0.54.
When is next earnings date of CEL-SCI Corp(CVM)?
The next earnings date of CEL-SCI Corp(CVM) is 2025-02-14 Est..
Does CEL-SCI Corp(CVM) pay dividends? If so, how much?
CEL-SCI Corp(CVM) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1